Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related death worldwide. Cutaneous metastases of signet-ring cell gastric carcinoma are uncommon. Here, we report a metastatic gastric adenocarcinoma, which manifested itself as an asymptomatic scar-like lesion on the epigastric area and histopathological features of the cutaneous lesion showing signet-ring cell.
Introduction
Cutaneous metastases of signet-ring cell gastric carcinoma (SRCC) are very rarely. [1] Cutaneous metastases are seen most frequently secondary to carcinomas of the breast, lung, colon, rectum, ovary, head, neck, kidney, and the gastrointestinal tract. [2] Here, we report a case of metastatic gastric adenocarcinoma, which manifested itself as an asymptomatic scar-like lesion on the epigastric area and histopathological features of the cutaneous lesion showing signet-ring cell.
Case Report
A 75-year-old female patient was admitted to hospital with a complaint of indurated scar-like lesions on the epigastric area [ Figure 1 ]. Her medical history revealed stage IIIa (T4aN1M0) gastric signet-ring cell adenocarcinoma, 3 years ago. At that time, she had undergone total gastrectomy and lymph node dissection. Her surgical pathology reports revealed cancer-free margin, and surgery was followed by adjuvant chemotherapy (infusional folinic acid + 5-Fluorouracil [FUFA]) and radiotherapy directed to the gastric lodge. The disease was in remission for 3 years. After 3 years, the patient presented with an asymptomatic indurated scar-like lesion on the epigastric area [ Figure 1 ]. An incisional biopsy was taken from the left hypochondriac skin. Histopathological sections showed diffuse dermal infiltration of cells with signet-ring morphology resulting from cutaneous metastasis of SRCC. Immunohistochemical studies showed positivity for pancytokeratin AE1-AE3 antibodies and negativity for GCDFP-15, CK7, S-100, HMB-45, MELAN A, and CD45 antibodies. The diagnosis of metastatic signet-ring cell carcinoma was made on the basis of the histopathological examination [Figures 2 and 3] . Computed tomography revealed progression to pretracheal, prevascular, subcarinal lymph nodes and pleural effusion, pericardial effusion. She was scheduled for a second round of chemotherapy (5-fluorouracil, infusional folinic acid, and oxaliplatin).
Discussion
Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related death worldwide. [3, 4] Gastric carcinoma has several classifications such as clinically, histologically, and on anatomic location-wise. [5] The 2010 WHO classification recognizes four major histologic patterns of gastric cancers: tubular, papillary, mucinous, and poorly cohesive (including signet-ring cell carcinoma). [6] The classification is based on the predominant histologic pattern of the carcinoma. SRCC is defined as a poorly cohesive carcinoma composed predominantly of tumor cells with prominent cytoplasmic mucin and a crescent-shaped ovaries, central nervous system, bone, pulmonary, or soft-tissue metastases occur. [8, 9] Rarely, internal cancers metastasize to the skin through the hematogenous or lymphatic spread of tumor cells. Internal cancer tumor cells may also be seen in the skin as a result of direct tissue invasion or iatrogenic implantation. [10] Clinically, cutaneous metastases of SRCC can be red or violet; they may present as a single or multiple hyperpigmented nodules, showing zosteriform, erysipelas-like, allergic contact dermatitis-like, cellulitis-like patterns, or scar-like lesions.
They have been reported to appear on the head, neck, eyebrow, chest, and fingertips. [5] In this case, the lesions were scar-like on the epigastric area. Since skin metastases are rare, attention should be given to patients with bizarre skin lesions. Lesions should be sampled by biopsy as was in our case.
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There are no conflicts of interest. nucleus eccentrically placed, according to the WHO classification. [7] SRCC has two main pathologic spreads. One of them is the loss of cell-cell adhesion molecules and the other one is accumulation of mucin in the large vacuoles. [5] The most common metastatic spread is to the liver, peritoneal surfaces, and nonregional or distant lymph nodes. Less commonly,
